Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara J Cooper

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
BMC Cancer|November 23, 2023
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancerCarter A Wright, Emily R Gordon, Sara J Cooper
Bioinformatics (Oxford, England)|December 28, 2017
R2DGC: threshold-free peak alignment and identification for 2D gas chromatography-mass spectrometry in RRyne C Ramaker, Emily R Gordon, Sara J Cooper
Genome Research|January 4, 2007
Serum response factor binding sites differ in three human cell typesSara J Cooper, Nathan D Trinklein, Loan Nguyen, et al.
BMC Cancer|June 8, 2023
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistanceEmily R Gordon, Carter A Wright, Mikayla James, et al.
Research Square|February 7, 2023
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistanceEmily R Gordon, Carter A Wright, Mikayla James, et al.
Plos Computational Biology|November 29, 2018
powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoireHillary Koch, Dmytro Starenki, Sara J Cooper, et al.
Genome Research|December 14, 2005
Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genomeSara J Cooper, Nathan D Trinklein, Elizabeth D Anton, et al.
HGG Advances|January 20, 2022
Characteristics and experiences of patients from a community-based and consumer-directed hereditary cancer population screening initiativeVeronica Greve, Katherine Odom, Susanna Pudner, et al.
Molecular Biosystems|November 19, 2010
Suppression of statin effectiveness by copper and zinc in yeast and human cellsDouglas M Fowler, Sara J Cooper, Jason J Stephany, et al.
BMC Cancer|May 29, 2021
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transitionRyne C Ramaker, Andrew A Hardigan, Emily R Gordon, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
BMC Cancer|November 23, 2023
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancerCarter A Wright, Emily R Gordon, Sara J Cooper
Bioinformatics (Oxford, England)|December 28, 2017
R2DGC: threshold-free peak alignment and identification for 2D gas chromatography-mass spectrometry in RRyne C Ramaker, Emily R Gordon, Sara J Cooper
Genome Research|January 4, 2007
Serum response factor binding sites differ in three human cell typesSara J Cooper, Nathan D Trinklein, Loan Nguyen, et al.
BMC Cancer|June 8, 2023
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistanceEmily R Gordon, Carter A Wright, Mikayla James, et al.
Research Square|February 7, 2023
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistanceEmily R Gordon, Carter A Wright, Mikayla James, et al.
Plos Computational Biology|November 29, 2018
powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoireHillary Koch, Dmytro Starenki, Sara J Cooper, et al.
Genome Research|December 14, 2005
Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genomeSara J Cooper, Nathan D Trinklein, Elizabeth D Anton, et al.
HGG Advances|January 20, 2022
Characteristics and experiences of patients from a community-based and consumer-directed hereditary cancer population screening initiativeVeronica Greve, Katherine Odom, Susanna Pudner, et al.
Molecular Biosystems|November 19, 2010
Suppression of statin effectiveness by copper and zinc in yeast and human cellsDouglas M Fowler, Sara J Cooper, Jason J Stephany, et al.
BMC Cancer|May 29, 2021
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transitionRyne C Ramaker, Andrew A Hardigan, Emily R Gordon, et al.
Pageof 6